Flatwoods Spring Seminar - School of Pharmacy

Registration Fee
Other Information
Registration Fee includes continuing education, seminars,
materials, breaks, and lunch. A late fee will be applied if the
fees are sent after 6/5 for Flatwoods.
For more information, contact Michael Kurilla, M.Ed., CE
Program Specialist, at (304) 293-5103 or
mpkurilla@hsc.wvu.edu, or Dr. Ginger Scott, CE Director at
(304)293-1553 or at vscott@hsc.wvu.edu. Visit us on the web
at http://pharmacy.hsc.wvu.edu/ce/Live-Programs.
All Day - 6 hr CE (circle rate)
Pharmacists
All Others
Fee
$130
$90
Late Fee
$160
$120
Half-Day Only
Pharmacists
All Others
$65
$45
$80
$60
Cancellation Policy
Locations
5/15 Barboursville
Holiday Inn, 3351 Rt. 60 East, Barboursville, WV 25504
Phone - (304) 733-3338
Directions: I-64 W to EXIT 20A and the hotel will be on the left
or EXIT 20 B and the hotel will be on the right.
6/7 Flatwoods
Refund minus a $25 fee will be given for cancellations
received in writing by 6/5 for Flatwoods. The Office of CE
reserves the right to cancel the program due to low
registration. If canceled, registrants will be contacted via
phone or e-mail.
Days Hotel, Sutton Flatwoods, WV
2000 Sutton Lane, Sutton, WV 26601
866-700-7284 or (304) 765-5055
Directions: From I-79, take Exit 67 (Flatwoods Exit). The hotel
is at the top of the hill.
Register Online
Continuing Education
Please register and pay online at
https://pharmacyce.wvu.edu/user/login. If you cannot
register online, please mail or fax the form below to:
WVU School of Pharmacy, Office of Continuing Education
PO Box 9540
Morgantown, WV 26505
Fax: 304-293-2529
Please Print or Type
___________________________________________________
FIRST NAME
MI
LAST NAME
___________________________________________________
STREET ADDRESS
___________________________________________________
CITY
STATE
ZIP
___________________________________________________
PHONE (Home and Work)
___________________________________________________
EMAIL ADDRESS
DIETARY RESTRICTIONS
Continuing Education
Programs for Pharmacists
West Virginia University School of Pharmacy
(WVUSoP) is accredited by the Accreditation
Council for Pharmacy Education (ACPE) as a
provider of continuing pharmacy education (CPE).
The Barboursville and Flatwoods programs are accredited up
to a total of 6.0 hours, or 0.6 CEUs for pharmacists. WVUSoP
will report your participation in the programs to NABP CPE
Monitor within 4 – 6 weeks for all participants who
successfully complete each session. Successful completion
includes: attending the entire session, signing the attendance
sheet and completing an online evaluation form for each
session attended. After completing the evaluation form, a
statement of credit may be printed on-line, by going to your
personal account in our database
http://pharmacyce.wvu.edu/user/login.
Barboursville Spring Seminar
Friday, May 15, 2015
8:00 am – 4:30 pm
Holiday Inn, Barboursville, WV
3 hrs. live Drug Diversion CE,
3hrs. additional live CE
Return Service Requested
(6 hrs CE) ______
(6 hrs CE) ______
WVU School of Pharmacy
Office of Continuing Education
PO Box 9540
Morgantown, WV 26506-9540
Barboursville Spring Seminar, May 15
Flatwoods Seminar, June 7
Flatwoods Spring Seminar
Sunday, June 7, 2015
8:00 am – 4:30 pm
Days Hotel, Flatwoods, WV
3 hrs. live Drug Diversion CE,
3hrs. additional live CE
Program Description
Programs are designed for pharmacists in all practice settings.
The Barboursville Seminar will focus on drug diversion
updates, West Virginia law update, and Medication Therapy
Management. The Flatwoods Seminar will focus on drug
diversion updates, new therapies for diabetes management,
and Immunization updates.
Agenda
May 15, 2015 – Barboursville Seminar
8:00am Registration and Refreshments
8:55am Welcome/Announcements
9:00am *Updates in Prescription Drug Diversion, Substance
Use Disorders, and Pain Management (Knowledgebased)
Michael O’Neil, PharmD
ACPE UPN 0072-0000-15-023-L03-P
10:30am Break
10:45am Resume Drug Diversion Presentation
12:15pm Lunch
1:15pm *West Virginia Pharmacy Law Update: 2015
(Knowledge-based)
David E. Potters, JD
ACPE UPN 0072-0000-15-035-L03-P
2:45pm Break
3:00pm Optimizing the Pharmacist's Role in Patient Care
through MTM (Application Based)
Ashleigh Barrickman, PharmD
ACPE UAN 0072-0000-15-038-L04-P
4:30pm Questions and Conclusion
*These sessions were originally presented on
4/26/2015 in Vienna, WV. If you attended one of
these sessions, additional credit will not be awarded.
June 7 – Flatwoods Seminar
8:00am Registration and Refreshments
8:55am Welcome/Announcements
9:00am *Updates in Prescription Drug Diversion, Substance
Use Disorders, and Pain Management (Knowledgebased)
Michael O’Neil, PharmD
ACPE UPN 0072-0000-15-023-L03-P
10:30am Break
10:45am Resume Drug Diversion Presentation
12:15pm Lunch
1:15pm New Therapies for the Management of Diabetes How Sweet It Is!
Charles D. Ponte, BSc, PharmD, DPNAP, FAADE,
FAPhA, FASHP, FCCP
ACPE UAN 0072-0000-15-039-L01-P
2:45pm Break
3:00pm **A Shot of Prevention: An Update on Current
Vaccination Recommendations (Knowledge-based)
Dani Dolin, PharmD, CDE, CPT
ACPE UPN 0072-0000-15-032-L01-P
4:30pm Questions and Conclusion
*This session was originally presented on 4/26/2015
in Vienna, WV, and 5/15/2015 in Barboursville, WV,
and 5/17/2015 in Wheeling, WV. If you attended
one of these sessions, additional credit will not be
awarded.
**This session was originally presented on 5/1/2015
in Morgantown, WV. If you attended this session,
additional credit will not be awarded.
Learning Objectives
Updates in Prescription Drug Diversion, Substance Use
Disorders, and Pain Management
• Discuss what comprises drug diversion, including West
Virginia statistics on prescription drug abuse and
resulting deaths.
• State the epidemiology of chronic pain and misuse of
opioids.
• Describe the indicators for opioids in chronic pain
treatment including general characteristics, toxicities,
and drug interactions.
• Outline patient evaluation and risk assessment and
tools to assess risk and monitor benefits.
• Explain the initiation and ongoing-management of
chronic pain in patients treated with opioid based
therapies.
• Discuss a case study of a patient with chronic pain.
• Identify diversion and drug seeking behaviors and
tactics.
• State best practice methods for working with patients,
prescribers, and law enforcement concerning patients
suspected of drug seeking behavior and diversion.
• Give examples of compliance with controlled
substances laws.
• Identify registration with and use of the West Virginia
Controlled Substances Monitoring Program
established in West Virginia Code 60A-9-1.
Barboursville
West Virginia Pharmacy Law Update: 2015 (Knowledge
Based)
• Discuss laws passed by the 2015 WV Legislature
related to pharmacy practice.
• Identify the expansion in types of immunizations given
by West Virginia pharmacists.
• Discuss federal changes for compounding for
prescriptions and for 503b outsourcing facilities.
Optimizing the Pharmacist's Role in Patient Care through
MTM– (Application-based)
• Define medication therapy management.
• Describe the components of an MTM session.
• Explain the goals of an effective MTM session.
• Define the benefits of MTM.
• Identify barriers to providing MTM in a community
pharmacy setting.
• Develop strategies for overcoming barriers to MTM.
• Assess medication profiles and develop medicationaction plans for patients.
Flatwoods
New Therapies for the Management of Diabetes - How
Sweet It Is!
• Describe the changing local and national landscape of
diabetes mellitus.
• Describe the major characteristics of the metabolic
syndrome and its association with cardiovascular risk
and diabetes.
• Discuss the new incretin-based therapies and their
role in the management of diabetes.
• Describe the role of the SGLT 2 inhibitors in the
management of type 2 diabetes.
A Shot of Prevention: An Update on Current Vaccination
Recommendations
• Compare the available influenza vaccinations and
determine how to select the most appropriate vaccine.
• Discuss similarities and differences between the
pneumococcal polysaccharide and conjugate vaccines.
• State the recommendations for tetanus-containing
vaccines in adults including target population and revaccination.
• Discuss meningococcal vaccines and administration.
Faculty
Barboursville
Michael O’Neil, PharmD
Professor of Pharmacy Practice
South College School of Pharmacy
Knoxville, TN
David E. Potters, JD
Executive Director and General Counsel
WV Board of Pharmacy
Charleston, WV
Ashleigh Barrickman, PharmD
Pharmacist in Charge (PIC)
White Hall Pharmacy
Fairmont, WV
Flatwoods
Michael O’Neil, PharmD
Professor of Pharmacy Practice
South College School of Pharmacy
Knoxville, TN
Charles D. Ponte, BSc, PharmD, DPNAP, FAADE, FAPhA,
FASHP, FCCP
Professor of Clinical Pharmacy and Family Medicine
West Virginia University
Robert C. Byrd Health Sciences Center
Schools of Pharmacy and Medicine
Morgantown, WV
Dani Dolin, PharmD, CDE, CPT
Clinical Pharmacist
Morgantown, WV